Words Matter Identical Does Not Mean Identical to a Portion of
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by: Douglas B. Wentzel and Tyler S. Cox
LABORATORY CORPORATION OF AMERICA HOLDINGS v. QIAGEN SCIENCES LLC
Before Lourie, Dyk, and Cunningham. Appeal from the United States District Court for the District of Delaware.
Summary: The Federal Circuit reversed the district court’s denial of JMOL of non-infringement, which rested on an incorrect construction of “identical” and was not supported by substantial evidence.
Labcorp sued Qiagen, alleging that Qiagen’s DNA sample sequencing kits infringed two Labcorp patents related to methods of preparing DNA samples for sequencing. At trial, the jury found that Qiagen infringed one patent under the doctrine of equivalents and literally infringed the other patent. After trial, the district court denied Qiagen’s motion for judgment as a matter of law (“JMOL”) of non-infringement. Qiagen appealed.
The Federal Circuit reversed. For one asserted patent, the Federal Circuit first found the district court erred in denying JMOL of non-infringement by allowing the jury to conclude that the claim term “identical” could mean “identical to a portion.” The court emphasized that such claim construction issues cannot be decided by the jury. The court also found “identical” cannot mean “identical to a portion of” because identical means “the same.” The Federal Circuit also found the accused product did not infringe the patent under the doctrine of equivalents because it failed all three prongs of the function-way-result test. For the other asserted patent, the Federal Circuit agreed there was insufficient evidence to support a verdict of literal infringement. Specifically, the Federal Circuit found the district court relied on evidence that failed to satisfy two requirements of the claim terms as construed by the district court. The court also rejected Labcorp’s argument that two components could in combination infringe the limitation in question, as the district court’s construction required the claimed functions to be performed by one component. Accordingly, the Federal Circuit reversed and remanded to the district court with instructions to grant JMOL of non-infringement on both asserted patents.
Editor: Sean Murray
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…